Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

被引：29

作者：

Bayle, A. ^{[1
]}

Khettab, M. ^{[2
]}

Lucibello, F. ^{[3
]}

Chamseddine, A. N. ^{[4
]}

Goldschmidt, V. ^{[5
]}

Perret, A. ^{[6
]}

Ropert, S. ^{[7
]}

Scotte, F. ^{[8
]}

Loulergue, P. ^{[9
]}

Mir, O. ^{[5
]}

机构：

[1] Gustave Roussy Canc Inst, Dept Drug Dev DITEP, Villejuif, France

[2] Gustave Roussy Canc Inst, Dept Canc Med, Chevilly Larue, France

[3] Paris Sci & Lettres Univ, Curie Inst, INSERM, U932, Paris, France

[4] Gustave Roussy Canc Inst, Dept Int Patients Canc Care, Villejuif, France

[5] Gustave Roussy Canc Inst, Ambulatory Canc Care, Villejuif, France

[6] Gustave Roussy Canc Inst, Canc Med, Villejuif, France

[7] Antony Private Hosp, Dept Med Oncol, Antony, France

[8] Foch Hosp, Dept Med Oncol, Suresnes, France

[9] Hotel Dieu Teaching Hosp, Dept Infect Dis, Paris, France

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 07期

关键词：

DOCETAXEL;

D O I：

10.1016/j.annonc.2020.03.290

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：959 / 961

页数：3

共 15 条

[1] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[2] Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer [J].

Chong, Curtis Robert ;

Park, Vivian ;

Harding, James J. ;

Brite, Jennifer ;

Wolchok, Jedd D. ;

Kamboj, Mini .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[3] Epidemiology and outcomes of serious influenza-related infections in the cancer population [J].

Cooksley, CD ;

Avritscher, EBC ;

Bekele, BN ;

Rolston, KV ;

Geraci, JM ;

Elting, LS .

CANCER, 2005, 104 (03) :618-628

[4] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[5] Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI). [J].

Gopalakrishnan, Ragisha ;

Johnson, Douglas Buckner ;

York, Sally ;

Neuss, Michael N. ;

Osterman, Travis John ;

Chism, David D. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[6] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer [J].

Horn, L. ;

Mansfield, A. S. ;

Szczesna, A. ;

Havel, L. ;

Krzakowski, M. ;

Hochmair, M. J. ;

Huemer, F. ;

Losonczy, G. ;

Johnson, M. L. ;

Nishio, M. ;

Reck, M. ;

Mok, T. ;

Lam, S. ;

Shames, D. S. ;

Liu, J. ;

Ding, B. ;

Lopez-Chavez, A. ;

Kabbinavar, F. ;

Lin, W. ;

Sandler, A. ;

Liu, S. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23) :2220-2229

[7] Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events [J].

Laeubli, Heinz ;

Balmelli, Catharina ;

Kaufmann, Lukas ;

Stanczak, Michal ;

Syedbasha, Mohammedyaseen ;

Vogt, Dominik ;

Hertig, Astrid ;

Mueller, Beat ;

Gautschi, Oliver ;

Stenner, Frank ;

Zippelius, Alfred ;

Egli, Adrian ;

Rothschild, Sacha I. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

[8] Low influenza vaccination rate among patients receiving chemotherapy for cancer [J].

Loulergue, P. ;

Mir, O. ;

Alexandre, J. ;

Ropert, S. ;

Goldwasser, F. ;

Launay, O. .

ANNALS OF ONCOLOGY, 2008, 19 (09) :1658

[9] Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study [J].

Loulergue, P. ;

Alexandre, J. ;

Iurisci, I. ;

Grabar, S. ;

Medioni, J. ;

Ropert, S. ;

Dieras, V. ;

Le Chevalier, F. ;

Oudard, S. ;

Goldwasser, F. ;

Lebon, P. ;

Launay, O. .

BRITISH JOURNAL OF CANCER, 2011, 104 (11) :1670-1674

[10] Intention to vaccinate against influenza among health care workers caring for immunocompromised patients [J].

Loulergue, Pierre ;

Kerneis, Solen ;

Stern, Jean-Baptiste ;

Kassis-Chikani, Najiby ;

Derradji, Ouda ;

Escaut, Lelia ;

Launay, Odile ;

Vittecoq, Daniel ;

Wyplosz, Benjamin .

AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (09) :1080-1082

← 1 2 →